Taken together, these findings demonstrate that BCKDK‐mediated RNF8 phosphorylation at S157 plays a critical role in tumor progression and contributes to resistance against DNA damage‐inducing therapy in breast cancer. Here, BCKDK is linked to breast carcinoma.